Achyut Healthcare P/E Ratio
Current P/E Ratio
790.0
High Valuation
Very High - High growth expectations or significantly overvalued
Achyut Healthcare (ACHYUT) P/E ratio is 790.0 (High), EPS (TTM) ₹0.01, current price ₹7.10 on BSE — Very High - High growth expectations or significantly overvalued. Read ACHYUT dividend payout details for the complete payout history and dividend yield track record.
Current Valuation Metrics
P/E Ratio
790.0
Current Price
₹7.10
EPS (TTM)
₹0.01
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
51.78
Sector Median
31.31
Sector Rank
#11 of 194
Sector Percentile
5.7%
ACHYUT P/E Ratio — Valuation Signal & Historical Context
Achyut Healthcare P/E 790.0 — signal: Overvalued. See Achyut Healthcare P/B ratio trends to compare market price against book value per share.
- Stock appears overvalued with PE of 790.0, suggesting caution for new investments
- Trading at premium to sector average PE of 51.78
ACHYUT vs Healthcare Peers — P/E Ratio Comparison
Achyut Healthcare P/E 790.0 vs Healthcare average 51.78, median 31.31 — range 2.86–916.67.
Sector Average
51.78
Sector Median
31.31
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.61 | ₹64 | Low |
| Sunrest Lifescience | SUNREST | 3.82 | ₹31 | Low |
| Shelter Pharma | SHELTER | 4.69 | ₹43 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.76 | ₹7,399 | Low |
| JFL Life Sciences | JFLLIFE | 5.46 | ₹72 | Low |
| Dipna Pharmachem | DPL | 5.78 | ₹15 | Low |
| Mono Pharmacare | MONOPHARMA | 5.82 | ₹18 | Low |
| Amwill Health Care | AMWILL | 7.15 | ₹82 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹90 | Low |